Content about Acquisition

October 19, 2012

Through a $100,000 gift to the Fashion Institute of Technology, an endowed scholarship has been established by cosmetics executive Leslie Blodgett, creator of BareMinerals and executive chairman of Bare Escentuals.

NEW YORK — Through a $100,000 gift to the Fashion Institute of Technology, an endowed scholarship has been established by cosmetics executive Leslie Blodgett, creator of BareMinerals and executive chairman of Bare Escentuals.

Blodgett is a 1985 graduate of FIT's Cosmetics and Fragrance Marketing program.

October 18, 2012

While Supervalu has completed its overhaul of its value proposition across its Jewel-Osco banner, the grocer will be analyzing the impact before replicating the price repositioning across its entire chain.

MINNEAPOLIS — While Supervalu has completed its overhaul of its value proposition across its Jewel-Osco banner, the grocer will be analyzing the impact before replicating the price repositioning across its entire chain, the Minnesota-based supermarket chain announced Thursday morning. "We continue to have a market-leading price position amongst conventional food retailers in three markets," Wayne Sales, Supervalu president, CEO and chairman told analysts during the second-quarter conference call.

September 27, 2012

Physicians Formula and Markwins International announced on Thursday that they have entered into a merger agreement under which Markwins will acquire all of the outstanding shares of common stock of Physicians Formula for $4.90 per share in cash, or approximately $74.9 million.

ZUSA, Calif. and CITY OF INDUSTRY, Calif. — Physicians Formula and Markwins International announced on Thursday that they have entered into a merger agreement under which Markwins will acquire all of the outstanding shares of common stock of Physicians Formula for $4.90 per share in cash, or approximately $74.9 million.

September 25, 2012

Valeant Pharmaceuticals International has acquired rights to a drug used to treat a symptom of age-related macular degeneration, the drug maker said.

MONTREAL — Valeant Pharmaceuticals International has acquired rights to a drug used to treat a symptom of age-related macular degeneration, the drug maker said.

Valeant announced that it acquired the injected drug Visudyne (verteporfin) from QLT, a company based in Vancouver, Canada.

Valeant said it paid $62.5 million upfront for all U.S. rights and available inventories for the drug, which had U.S. sales of about $21 million in 2011, and another $50 million upfront for rights to non-U.S. sales, which were about $14 million.

September 25, 2012

As the largest single purchaser of prescription drugs in the world, with a global pharmaceutical wholesale operation to match, in-house manufacturing capabilities in over-the-counter health and wellness and generic drugs, Walgreens-Alliance Boots will have a whole lot more influence on the pharmacy side of its business.


Much has been written already about Walgreens’ epic, two-step acquisition of Alliance Boots that in the end could be valued at $16 billion. As the largest single purchaser of prescription drugs in the world, with a global pharmaceutical wholesale operation to match, in-house manufacturing capabilities in over-the-counter health and wellness and generic drugs, Walgreens-Alliance Boots will have a whole lot more influence on the pharmacy side of its business.


September 19, 2012

Beauty company Coty has appointed Jean Mortier as president of its Prestige business, effective immediately.

NEW YORK — Beauty company Coty has appointed Jean Mortier as president of its Prestige business, effective immediately.

Mortier has served as SVP, commercial for Coty since 2005. He succeeds Michele Scannavini, who was named CEO of Coty in July after serving as president of Coty Prestige for 10 years. In his new capacity, Mortier will lead the continued development and growth of the Coty Prestige portfolio, as well as seek new business ventures and collaborations. Based in Paris, he will also serve on Coty's executive committee.

September 18, 2012

Over the last few years of DSN’s coverage of the impending patent cliff and how it would affect the generic drug industry, IMS Health VP industry relations Doug Long predicted that the gradual commoditization of primary care drugs — long the lifeblood of generic drug makers — would lead to consolidation of the industry.


Over the last few years of DSN’s coverage of the impending patent cliff and how it would affect the generic drug industry, IMS Health VP industry relations Doug Long predicted that the gradual commoditization of primary care drugs — long the lifeblood of generic drug makers — would lead to consolidation of the industry.


September 5, 2012

Kimberly-Clark has issued a consumer advisory — as a result of suspected criminal activity — regarding a number of defective lots of Kotex Natural Balance Security tampons that may pose public health risks to consumers.

DALLAS — Kimberly-Clark has issued a consumer advisory — as a result of suspected criminal activity — regarding a number of defective lots of Kotex Natural Balance Security tampons that may pose public health risks to consumers.

While the health risk to consumers is low, some of these tampons have: Increased levels of bacteria; presence of metallic particles; or imperfect raw materials.

September 5, 2012

Yellow Wood Partners has acquired mass market fragrance provider Parfums de Coeur, whose brands include Body Fantasies, Designer Imposters and BOD Man.

BOSTON —Yellow Wood Partners has acquired mass market fragrance provider Parfums de Coeur, whose brands include Body Fantasies, Designer Imposters and BOD Man.

Yellow Wood is acquiring PDC in partnership with the company’s management team, who also are investing equity into the business. Financial terms of the deal were not disclosed.

September 4, 2012

Canadian drug maker Valeant Pharmaceuticals International is buying Medicis Pharmaceutical for $2.6 billion, Valeant said Monday.

MONTREAL — Canadian drug maker Valeant Pharmaceuticals International is buying Medicis Pharmaceutical for $2.6 billion, Valeant said Monday.

The $44-per-share deal, which the companies said represents a 39% premium over the closing price of Medicis' shares on Friday, is expected to close in the first half of 2013.

August 28, 2012

Merz announced it has acquired a medication designed to treat a condition associated with such neurologic conditions as cerebral palsy.

GREENSBORO, N.C. — Merz announced it has acquired a medication designed to treat a condition associated with such neurologic conditions as cerebral palsy.

August 24, 2012

As several suitors eye individual parts of the Supervalu business, Bloomberg reported that Supervalu is seeking buyers to bid for the entire business.

MINNEAPOLIS — As several suitors eye individual parts of the Supervalu business, Bloomberg reported that Supervalu is seeking buyers to bid for the entire business.

The news sparked a rise in Supervalu shares on Friday. As of press time, shares of Supervalu were up more than 9% to $2.32.

August 10, 2012

BioScrip on Wednesday posted $155.9 million in second-quarter revenue, up 18.5% compared with the prior year.

ELMSFORD, N.Y. — BioScrip on Wednesday posted $155.9 million in second-quarter revenue, up 18.5% compared with the prior year.

"The second-quarter results demonstrate our progress in executing on our strategic plan," BioScrip president and CEO Rick Smith said. "We were able to close on the divestiture of the noncore pharmacy services assets and redeploy a portion of the proceeds towards the acquisition of InfuScience, while delivering sequential improvement on our adjusted EBITDA."

August 8, 2012

Bristol-Myers Squibb has bought a majority stake in drug maker Amylin Pharmaceuticals, Bristol said Wednesday.

NEW YORK — Bristol-Myers Squibb has bought a majority stake in drug maker Amylin Pharmaceuticals, Bristol said Wednesday.

The New York-based drug maker said that 140.5 million shares of Amylin had been put up for sale at $31 per share, and that it now owned 85.55% of the San Diego-based company. Bristol said it planned to acquire the rest of Amylin's shares Wednesday as well.

August 1, 2012

Beiersdorf’s Nivea brand has announced the launch of its first-ever Nivea "Kiss of Style" design contest, which will give one winner the opportunity to design a limited-edition cap for Nivea Lip Care that will be sold in stores.

NEW YORK — Beiersdorf’s Nivea brand has announced the launch of its first-ever Nivea "Kiss of Style" design contest, which will give one winner the opportunity to design a limited-edition cap for Nivea Lip Care that will be sold in stores.

August 1, 2012

Campbell's confirmed that a new leader will take over the company's Pepperidge Farm business.

CAMDEN, N.J. — Campbell's confirmed that a new leader will take over the company's Pepperidge Farm business.

Irene Chang Britt, who has worked at Campbell's since 2005, will replace Pat Callaghan as president of Pepperidge Farm. Britt is the first woman to lead Pepperidge Farm since company founder Margaret Rudkin presided over the business from 1937 to 1966. Pepperidge Farm was acquired by Campbell's in 1961.

Britt will be based at Pepperidge Farm's headquarters in Norwalk, Conn., and will report to Campbell's president and CEO Denise Morrison.

July 31, 2012

An Ahold USA executive has received honors from a New England business publication.

CARLISLE, Pa. — An Ahold USA executive has received honors from a New England business publication.

Ahold USA announced Tuesday that EVP and CFO Paula Price was named 2012 CFO of the Year in the public company category by the Boston Business Journal and was honored at the newspaper's annual luncheon last Wednesday. Ahold USA, a subsidiary of Netherlands-based Royal Ahold, operates the Stop & Shop, Giant-Landover and Giant-Carlisle supermarket chains and the Peapod online grocery service.

July 27, 2012

McLane has entered into an agreement to acquire Meadowbrook Meat Co.

TEMPLE, Texas — McLane has entered into an agreement to acquire Meadowbrook Meat Co.

McLane said MBM — which is one of the nation's largest customized foodservice distributors for national restaurant chains — will continue to be led by the current executive management team and operating out of its existing facilities in the same markets. McLane's acquisition is subject to customary closing conditions, including the termination of the applicable waiting period under the Hart-Scott-Rodino Act.

July 20, 2012

A division of Nestle has bought a stake in a Colorado-based drug maker focused on treatments for neurodegenerative diseases.

BROOMFIELD, Colo. — A division of Nestle has bought a stake in a Colorado-based drug maker focused on treatments for neurodegenerative diseases.

July 11, 2012

Land O'Lakes announced it has agreed to acquire Kozy Shack.

ARDEN HILLS, Minn. — Land O'Lakes announced it has agreed to acquire Kozy Shack.

Kozy Shack, based in New York and founded by Vincent Gruppuso more than 40 years ago, is a "strong strategic fit" for Land O'Lakes and "opens the door for Land O'Lakes to achieve future growth in the attractive dairy dessert category," Land O'Lakes president and CEO Chris Policinski said.

Terms of the acquisition were not disclosed. The transaction is subject to customary closing conditions. The deal is expected to close on July 31.

July 9, 2012

Jel Sert has acquired three functional beverage brand names from Solis Brands.

WEST CHICAGO, Ill. — Jel Sert has acquired three functional beverage brand names from Solis Brands.

July 9, 2012

Narrow networks. They're all the rage.

WHAT IT MEANS AND WHY IT'S IMPORTANT — Narrow networks. They're all the rage. If nothing else, narrow pharmacy benefit management networks emphasize local; and one analysis thread common among all the pundits discussing Walgreens' recent acquisition of USA Drug is that Walgreens just got a whole lot more local across the Southeast.

July 2, 2012

Bristol-Myers Squibb is acquiring Amylin Pharmaceuticals, the drug maker said Friday.

NEW YORK — Bristol-Myers Squibb is acquiring Amylin Pharmaceuticals, the drug maker said Friday.

Bristol announced that it would acquire Amylin for $5.3 billion, or $31 per share. The total value of the acquisition is about $7 billion, including $1.7 billion in Amylin's contractual payment and debt obligations.

June 21, 2012

Taken together, asthma and chronic obstructive pulmonary disease — which includes chronic bronchitis and emphysema — affect nearly 50 million Americans, or about 15% of the total U.S. population, according to statistics from such organizations as the Centers for Disease Control and Prevention.

Taken together, asthma and chronic obstructive pulmonary disease — which includes chronic bronchitis and emphysema — affect nearly 50 million Americans, or about 15% of the total U.S. population, according to statistics from such organizations as the Centers for Disease Control and Prevention. And combined, the two diseases cause more than 100,000 deaths per year. Fortunately, however, there is a wide range of treatments available for both, many of which work for both diseases.


June 18, 2012

The Federal Trade Commission has approved Giant Food Stores' proposal to acquire 15 Genuardi's stores from Safeway.

CARLISLE, Pa. — The Federal Trade Commission has approved Giant Food Stores' proposal to acquire 15 Genuardi's stores from Safeway.

The announcement follows Giant's Jan. 5 announcement that it would acquire the Genuardi's stores, all of which are located in the greater Philadelphia market. Giant also noted that under the terms of a consent order approved by the FTC, the Genuardi's located in Newtown, Pa., will be purchased by Newtown Market and will be operated as a McCaffrey's supermarket.